Background & aims The incidence of inflammatory bowel disease (IBD) is increasing
internationally, particularly in nations with historically low rates. Previous reports of the …

Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …

New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade
to become a global disease. The increasing number of studies on the incidence and course …

Background Ulcerative colitis is a chronic inflammatory bowel disease with an estimated 150
000 patients in Germany alone. Methods This review is based on publications about current …

1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

Crohn's disease and ulcerative colitis have emerged as global diseases. They affect over 2
million individuals in the North America, 3.2 million in Europe, and millions more worldwide …

The human gastrointestinal tract is inhabited by a vast number of microorganisms that are
called as the microbiota. Each individual harbors a unique gut microbial composition, this …

The roles of Rev-erbα and circadian clock in colonic inflammation remain unclarified. Here
we show colon clock genes (including Rev-erbα) are dysregulated in mice with DSS …